Lead optimization of antimalarial propafenone analogues

David Lowes, Anupam Pradhan, Lalitha V. Iyer, Toufan Parman, Jason Gow, Fangyi Zhu, Anna Furimsky, Andrew Lemoff, W. Armand Guiguemde, Martina Sigal, Julie A. Clark, Emily Wilson, Liang Tang, Michele C. Connelly, Joseph L. Derisi, Dennis E. Kyle, Jon Mirsalis, R. Kiplin Guy

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Previously reported studies identified analogues of propafenone that had potent antimalarial activity, reduced cardiac ion channel activity, and properties that suggested the potential for clinical development for malaria. Careful examination of the bioavailability, pharmacokinetics, toxicology, and efficacy of this series of compounds using rodent models revealed orally bioavailable compounds that are nontoxic and suppress parasitemia in vivo. Although these compounds possess potential for further preclinical development, they also carry some significant challenges.

Original languageEnglish
Pages (from-to)6087-6093
Number of pages7
JournalJournal of Medicinal Chemistry
Issue number13
StatePublished - Jul 12 2012

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Lead optimization of antimalarial propafenone analogues'. Together they form a unique fingerprint.

Cite this